Busulfan plus fludarabine as a myeloablative conditioning regimen compared with busulfan plus cyclophosphamide for acute myeloid leukemia in first complete remission undergoing allogeneic hematopoietic stem cell transplantation: a prospective and multicenter study

OBJECTIVE: We conducted a prospective, randomized, open-label, multicenter study to compare busulfan plus fludarabine (BuFlu) with busulfan plus cyclophosphamide (BuCy) as the conditioning regimen in allogeneic hematopoietic stem cell transplantation (allo-HSCT) for acute myeloid leukemia (AML) in f...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Hui, Zhai, Xiao, Song, Zhaoyang, Sun, Jing, Xiao, Yang, Nie, Danian, Zhang, Yu, Huang, Fen, Zhou, Hongsheng, Fan, Zhiping, Tu, Sanfang, Li, Yonghua, Guo, Xutao, Yu, Guopan, Liu, Qifa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571894/
https://www.ncbi.nlm.nih.gov/pubmed/23394705
http://dx.doi.org/10.1186/1756-8722-6-15

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571894/
https://www.ncbi.nlm.nih.gov/pubmed/23394705
http://dx.doi.org/10.1186/1756-8722-6-15

Ejemplares similares